The meeting of the UN Commission on Narcotic Drugs held in Vienna this spring showed how international drug policy is moving slowly. That is why every entry on harm reduction, human rights and public health is politically significant – a guest article by Aleksi Hupli, a Finnish researcher, first published in Finnish by A-Clinic Foundation.

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.

The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Transnational Institute this year after decades of work, has been at the forefront of these debates. In this interview, we discuss the WHO’s coca review, inter se treaty reform, and what these shifts mean for the future of global drug policy.

Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug policy. We spoke with Marie Nougier about what has changed over the past decade—and what still needs to change.

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global networks advocating for drug policies grounded in human rights, public health, and social justice. In this interview, we reflect on IDPC’s achievements, ongoing challenges, and what lies ahead.

We spoke with Pavel Bém, a Czech psychiatrist and former mayor of Prague in Vienna during the 69th session of the Commission on Narcotic Drugs (CND) about the country’s latest reforms—from cannabis regulation to psychedelic therapy—and what they mean for the future of drug policy in Europe.

Civil society and drug user activists push harm reduction reforms across the Nordic region – please watch the videos from a side event at the UN Commission on Narcotic Drugs (CND) and learn more about drug policy reform in Scandinavia!

On the eve of her departure from her post as the Ambassador of Colombia to Austria and Permanent Representative to the United Nations in Vienna, we spoke to Ambassador Laura Gil about her time in Vienna, her achievements, the challenges she faced as well as her hopes for the future of international drug policy.

At the 28th Harm Reduction International Conference, we spoke with Diego Andrés Lugo-Vivas about the impact of the Drug War in Colombia and how the philosophy of harm reduction could be applied to the coca leaf. Watch the video!

The Trump administration’s slashing of foreign aid is already having a devastating impact on harm reduction and HIV services around the world. But the harmful effects extend far beyond that. Drugreporter interviewed key experts at the annual UN drugs meeting, the CND in Vienna, to provide a clear picture of the real impacts.